Menu

Reproductive & Sexual Health

People who have more control over their childbearing and reproductive health have more control over their lives. Policies and programs that support girls and women unlock economic advancement, educational opportunity and better health for communities around the globe. PHI has worked for a half century to empower women and girls in the United States and globally, through research, advocacy and leadership programs, including evidence-based comprehensive sexuality education, advocacy, positive youth development, research and development of new tools to provide women control over pregnancy, and organizational and professional development. PHI experts launch and sustain programs that equip community members with the skills they need to become health advocates for sexual and reproductive health, with extensive experience developing world-renowned leadership programs for cis- and transwomen, youth, low-income populations and communities of color.

 

Our expertise can make your work stronger

See how PHI can work with you to support or lead your work on this issue.

Our Impact

See all Reproductive & Sexual Health Impacts

Pregnant woman
  • 130K Central American youth reached with accurate sexual and reproductive health information from GoJoven and Fellows
  • 1.2K funders, developers & researchers collaborating on MPTs
  • 7x increase in risk of cardiovascular disease death associated with some combinations of pregnancy complications

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org